Prescription patterns of inhaled corticosteroids for preschool children--A Norwegian register study

Knut Øymar1,2, Ingvild Bruun Mikalsen1, Kari Furu3

  • 1Department of Paediatrics, Stavanger University Hospital, Stavanger, Norway.

Insights

Inhaled corticosteroid (ICS) use in preschool children is high but often short-term, indicating potential overuse for asthma-like symptoms. Guidelines for restrictive ICS use in young children may need better implementation.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Pharmacotherapy

Background:

  • Asthma and wheeze symptoms in preschool children often overlap, complicating inhaled corticosteroid (ICS) prescription decisions.
  • Previous research indicates potential inappropriate prescribing patterns of ICS in this young age demographic.
  • This study examines trends and persistence of ICS use in Norwegian preschoolers from 2004-2013.

Purpose of the Study:

  • To analyze time trends in inhaled corticosteroid (ICS) utilization among preschool children in Norway.
  • To investigate patterns of ICS use by age, gender, and physician specialty.
  • To assess the persistence of ICS treatment throughout the preschool years.

Main Methods:

  • Utilized data from the Norwegian Prescription Database for the period 2004-2013.
  • Included children aged 5 years or younger prescribed ICS, alone or in combination.
  • Analyzed prescription data to determine prevalence, age/gender distribution, and treatment duration.

Main Results:

  • One-year prevalence of ICS use was high, peaking in 2010 before declining; highest in 2-year-olds and more common in boys.
  • 40-50% of ICS users received only one prescription annually, indicating low treatment persistence.
  • General practitioners issued the majority of prescriptions, with their share increasing over time.

Conclusions:

  • High prevalence but low persistence of ICS prescriptions suggest frequent use for intermittent asthma-like symptoms in preschoolers.
  • Current findings highlight a potential gap in adherence to asthma guidelines recommending restricted ICS use in early childhood.
  • Further actions may be necessary to ensure better implementation of established guidelines for ICS therapy in young children.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
842
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K